Search

Search Results
Results 87941 - 87950 of 88303 for cancer
  • News - 16 Feb 2010
    Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov....
  • News - 16 Feb 2010
    “The Meda Group expects to achieve sales of about SEK 13,000 million and an EBITDA of about SEK 4,200 million for full-year 2009.”
  • News - 11 Feb 2010
    Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the fourth quarter and year...
  • News - 21 Jan 2010
    UnitedHealth Group today reported growth in revenues and net earnings per share in 2009. The Company earned $0.81 per share in the fourth quarter, bringing full year 2009 net earnings to $3.24 per...
  • News - 22 Mar 2009
    The U.S. Food and Drug Administration is expanding, for the second time, its nationwide alert to consumers about tainted weight loss products containing
  • Drug - 10 Feb 2026
    Consumer Medicine Information (CMI) about Thymoglobuline intended for persons living in Australia.
  • Drug - 27 Jan 2026
    Consumer Medicine Information (CMI) about Trajentamet intended for persons living in Australia.
  • Drug - 27 Jan 2026
    Consumer Medicine Information (CMI) about Jardiamet intended for persons living in Australia.
  • Drug - 27 Jan 2026
    Consumer Medicine Information (CMI) about Pariet 10 intended for persons living in Australia.
  • Drug - 20 Jan 2026
    Consumer Medicine Information (CMI) about Sogroya intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.